WGS Q2 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q2 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$103M+45.6% YoY

Gross Profit

$71M69.0% margin

Operating Income

$9M8.7% margin

Net Income

$11M10.5% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+17.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$8M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$464M

Total Liabilities

$187M

Stockholders' Equity

$277M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103M	$71M	+45.6%
Gross Profit	$71M	$43M	+65.1%
Operating Income	$9M	-$11M	+184.7%
Net Income	$11M	-$29M	+137.1%

Revenue Segments

Diagnostic Test

$100M49%

Diagnostic Test, Third Party Insurance

$81M40%

Diagnostic Test, Institutional Customers

$18M9%

Product and Service, Other

$3M1%

Diagnostic Test, Self Pay

$339,0000%